Search Results - "Dayan, Gustavo"
-
1
Economic Impact of Dengue Illness in the Americas
Published in The American journal of tropical medicine and hygiene (01-02-2011)“…The growing burden of dengue in endemic countries and outbreaks in previously unaffected countries stress the need to assess the economic impact of this…”
Get full text
Journal Article -
2
Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks?
Published in Clinical infectious diseases (01-12-2008)“…Increased reports of mumps in vaccinated populations prompted a review of the performance of mumps vaccines. The effectiveness of prior vaccination with 1 dose…”
Get full text
Journal Article -
3
Review: The History of Dengue Outbreaks in the Americas
Published in The American journal of tropical medicine and hygiene (01-10-2012)Get full text
Journal Article -
4
Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials
Published in PLoS neglected tropical diseases (14-07-2016)“…A recombinant live attenuated tetravalent dengue vaccine (CYD-TDV) has been shown to be efficacious in preventing virologically-confirmed dengue disease,…”
Get full text
Journal Article -
5
The history of dengue outbreaks in the Americas
Published in The American journal of tropical medicine and hygiene (01-10-2012)“…Dengue is a viral disease usually transmitted by Aedes aegypti mosquitoes. Dengue outbreaks in the Americas reported in medical literature and to the Pan…”
Get full text
Journal Article -
6
The Epidemiology of Dengue in the Americas Over the Last Three Decades: A Worrisome Reality
Published in The American journal of tropical medicine and hygiene (01-01-2010)“…We have reported the epidemic patterns of dengue disease in the Region of the Americas from 1980 through 2007. Dengue cases reported to the Pan American Health…”
Get full text
Journal Article -
7
Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention
Published in Expert review of vaccines (01-11-2016)“…Staphylococcus aureus is both a commensal organism and also an important opportunistic human pathogen, causing a variety of community and hospital-associated…”
Get more information
Journal Article -
8
Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: Randomized Controlled Phase 1 Trial of Safety and Immunogenicity
Published in The Pediatric infectious disease journal (01-01-2011)“…Preliminary results in healthy, young US adults showed that a tetravalent, live-attenuated dengue vaccine (TDV) was safe and immunogenic, but no data are…”
Get full text
Journal Article -
9
Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA
Published in Vaccine (17-10-2013)“…Highlights • CYD-TDV is a tetravalent candidate dengue vaccine. • Immune response is imbalanced with a reduced dose of serotype 4 antigen. • Our results…”
Get full text
Journal Article -
10
Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus
Published in Vaccine (22-09-2020)“…•CYD-TDV was efficacious in dengue seropositives aged ≥ 9 years from dose 1 to M25.•Inter-dose efficacy was similar to that post-dose 3 in seropositives…”
Get full text
Journal Article -
11
Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials
Published in The Lancet infectious diseases (01-04-2021)“…The tetravalent dengue vaccine (CYD-TDV) has been shown to provide protection against dengue disease over 5-year follow-up in participants with previous dengue…”
Get full text
Journal Article -
12
Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age
Published in Vaccine (19-10-2012)“…Highlights ► ChimeriVax-WN02 is a live attenuated vaccine for protection against West Nile virus. ► We assessed the immunogenicity and safety of…”
Get full text
Journal Article -
13
Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus
Published in Vaccine (23-04-2020)“…•CYD-TDV efficacy was maintained for up to 6 years in seropositives aged ≥9 years.•Persistent CYD-TDV efficacy was also observed in seropositives aged…”
Get full text
Journal Article -
14
Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil
Published in The American journal of tropical medicine and hygiene (01-12-2013)“…Immunogenicity and safety of a recombinant, live-attenuated, tetravalent dengue disease vaccine (CYD-TDV) was evaluated in children/adolescents in Brazil. In…”
Get full text
Journal Article -
15
Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America
Published in Clinical infectious diseases (15-09-2021)“…Abstract Background CYD-TDV, a live, attenuated, tetravalent dengue vaccine, has been approved for the prevention of symptomatic dengue in previously dengue…”
Get full text
Journal Article -
16
Implications of a 2005 Measles Outbreak in Indiana for Sustained Elimination of Measles in the United States
Published in The New England journal of medicine (03-08-2006)“…In 2005, an outbreak of measles occurred that was traced to a student who had returned home to Indiana from a trip to Romania. At a gathering attended by the…”
Get full text
Journal Article -
17
Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries
Published in Transactions of the Royal Society of Tropical Medicine and Hygiene (01-07-2021)“…Abstract Background The recombinant tetravalent live-attenuated dengue vaccine based on the YF 17D vaccine virus backbone (CYD-TDV) demonstrated vaccine…”
Get full text
Journal Article -
18
Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus
Published in Viruses (09-12-2013)“…Substantial success has been achieved in the development and implementation of West Nile (WN) vaccines for horses; however, no human WN vaccines are approved…”
Get full text
Journal Article Book Review -
19
Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults
Published in The Journal of infectious diseases (01-01-2011)“…Background. ChimeriVax-WN02 is a live, attenuated chimeric vaccine for protection against West Nile virus. This Phase II, randomized, double-blind,…”
Get full text
Journal Article -
20
Recent Resurgence of Mumps in the United States
Published in The New England journal of medicine (10-04-2008)“…In 2006, the United States had the largest mumps outbreak in two decades. A total of 6584 cases were reported, with an estimated incidence of 2.2 cases per…”
Get full text
Journal Article